Outcomes of octogenarian (≥80 yo) patients with advanced non-small cell lung cancer (NSCLC): A single institution experience at the Christie Hospital

被引：2
|
作者：
Howell, M. [1 ]
Chiramel, J. [1 ]
Flaum, N. [1 ]
Lewis, A. [1 ]
Summers, Y. [1 ,2 ]
Taylor, P. D. [1 ,2 ]
Chittalia, A. [3 ]
Sheikh, H. [3 ]
Blackhall, F. [1 ,4 ]
Califano, R. [1 ,2 ]
机构：
[1] Christie NHS Fdn Trust, Canc Res UK Dept Med Oncol, Manchester, Lancs, England
[2] Univ Hosp South Manchester NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England
[4] Univ Manchester, Manchester, Lancs, England
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/j.lungcan.2015.10.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [21] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    [J]. LUNG CANCER, 2002, 38 : S47 - S50
  • [22] An evaluation of concurrent chemoradiotherapy practice for locally advanced non-small cell lung cancer (NSCLC) in a single centre institution
    Beardsworth, Sophie
    Bayman, Neil
    Coote, Joanna
    Cove-Smith, Laura
    Faivre-Finn, Corinne
    Harris, Margaret
    Salem, Ahmed
    Sheikh, Hamid
    Taylor, Paul
    Woolf, David
    Fenemore, Jackie
    Chan, Clara
    [J]. LUNG CANCER, 2022, 165 : S51 - S52
  • [23] The BC Cancer Agency experience with gefitinib in advanced non-small cell lung cancer (NSCLC)
    Ho, C
    Murray, N
    Melosky, B
    Laskin, J
    Anderson, H
    Karim, RR
    Hamata, L
    Bebb, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 220S - 220S
  • [24] Prospective Molecular Study of 22 Genes by NGS in Patients with Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Single Institution Experience
    Denninghoff, V.
    Recondo, G.
    Cuello, M.
    Romano, V.
    Wainsztein, V.
    Galanternik, F.
    Greco, M.
    De La Vega, M.
    Avagnina, M. A.
    Recondo, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2125 - S2125
  • [25] GEFITINIB in advanced non-small cell lung cancer (NSCLC) in expanded access programme: A single center experience
    Kowalczyk, A.
    Szutowicz-Zielinska, E.
    Dziadziuszko, R.
    Badzio, A.
    Madrzak, J.
    Kukowska, A.
    Siemiatkowska, A.
    Limon, J.
    Jassem, J.
    [J]. LUNG CANCER, 2006, 52 : S36 - S36
  • [26] Nivolumab Outcomes in Octogenarian Patients with Advanced Non-Small Cell Lung Cancer in French Real-World Setting
    Assie, J.
    Cotte, F.
    Levra, M. Giaj
    Calvet, C.
    Jolivel, R.
    Jouaneton, B.
    Gaudin, A.
    Grumberg, V.
    Chouaid, C.
    Corre, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S708 - S708
  • [27] Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
    Rapoport, Bernardo Leon
    Smit, Teresa
    van Eeden, Ronwyn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [28] Treatment Outcomes of Combine Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Single Institution Study
    Klunklin, Pitchayaponne
    Chitapanarux, Imjai
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S850 - S850
  • [29] Outcomes of Non-Small Cell Lung Cancer Patients with Brain Metastasis Treated by Whole Brain Radiotherapy, a Single Institution Experience
    Giridharan, S.
    Jegannathen, A.
    Vengalil, S.
    Gilani, S.
    Weli, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S949 - S950
  • [30] EVOLUTION OF CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL CELL LUNG CANCER (NSCLC). SINGLE INSTITUTION EXPERIENCE IN 600 PATIENTS
    Jeremic, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S343 - S344
12345